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Welcome to the second report from the National 
Perinatal Epidemiology Centre (NPEC) Audit of 
Severe Maternal Morbidity in Ireland. This is also 
the first report published by the NPEC since it 
aligned with the National Office of Clinical Audit 
(NOCA). The NOCA was established in 2012 with 
the purpose of providing assisted governance 
to sustainable clinical audit programmes 
across all health services at national level in 
order to improve outcomes for Irish patients. 
Our participation in NOCA ensures a process 
by which we can close the audit loop. This 
begins with bench marking clinical care with 
identified standards, such as those set by the 
National Clinical Programme in Obstetrics and 
Gynaecology, the Institute of Obstetrics and 
Gynaecology and the Faculty of Paediatrics, 
and ends with implementing change for the 
improvement of patient safety and quality of 
care. The NOCA Governance Board endorsement 
of this Report is in Appendix A.
Severe maternal morbidity (SMM) has gained 
much attention in developed countries over 
the last decade as an important quality 
indicator of obstetric care and maternal 
welfare. The main reason for this is that 
maternal mortality, historically used as a 
quality indicator of maternity services, is now 
very low in high-resourced countries. Further, 
there is evidence that commonly occurring 
life-threatening complications, such as 
major obstetric haemorrhage (MOH), are 
underexposed as they less frequently lead to 
death in high-resourced countries.
The absence of international consensus 
on definitions of SMM is problematic and 
impedes comparative analysis between 
similarly resourced countries. Whereas some 
definitions have included management-based 
systems and an organ-based definition, 
others propose a morbidity continuum, 
beginning with health and normal pregnancy, 
moving along the spectrum of morbid events 
to death. This concept, described by Mantel 
et al.1, conveys that maternal death only 
represents the ‘tip of the iceberg’.
In this context, the NPEC established 
a multidisciplinary specialist Maternal 
Morbidity Advisory Group in 2010 to advise 
on the investigation of SMM in Ireland: 
members of the Group are listed in Appendix 
B. In collaboration with the Maternal Morbidity 
Advisory Group, the NPEC has collected 
and analysed anonymised maternal 
morbidity data from Irish units since 2011 
using the validated and respected Scottish 
Confidential audit (SCASMM) methodology. 
This has allowed for comparison of maternal 
outcomes with a relatively similar health care 
provision service and pregnant population. 
The NPEC would like to acknowledge with 
thanks the Reproductive Health Programme 
of the National Health Service (NHS) Quality 
Improvement Scotland for permission 
to modify and use their Severe Maternal 
Morbidity Notification and Major Obstetric 
Haemorrhage forms for use in Ireland.
Measurement of the outcome of care in Irish 
maternity services is central to the development 
of safe and high quality health care. Support 
from all Irish maternity units is instrumental 
in the success of this national audit. On behalf 
of the NPEC, I extend my sincere thanks and 
appreciation to the many midwives, obstetricians 
and administration staff who have voluntarily 
contributed data to this audit (Appendix C). This 
is particularly laudable considering the impact 
on staffing levels resulting from the ongoing 
recruitment moratorium within the Health 
Service Executive (HSE).
1   Mantel G et al. Severe Acute maternal morbidity: a pilot study of a definition for a near-miss. BJOG 1998; 105: 985-90.
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For the first three years of this national audit of 
SMM, a detailed assessment of cases of major 
obstetric haemorrhage was undertaken. This 
had provided a very valuable assessment of 
the most common and significant maternal 
morbidity as detailed in this Report. In 
addition, unsolicited feedback from units has 
suggested other valuable effects of partaking 
in national audits. Specific examples include 
the following: 
“this highlighted the significant number of 
patients being transfused and led to a review 
of our transfusion policy”
“on completing the detailed audit form, 
we documented in our unit inconsistent 
approaches in the order of procedures to 
arrest bleeding”
“this provided an excellent audit tool and 
allowed a standard approach to evaluating 
our MOH cases”
“this audit led to improved multidisciplinary 
interaction in assessment of our cases”
“the feedback and comparison with other 
units is very valuable”
I would also like to acknowledge and thank 
members of the Maternal Morbidity Advisory 
Group (Appendix B) for their intellectual input 
and guidance in implementing this audit 
nationally.
Instrumental to the success of the NPEC, 
as it continues to grow and evolve, is the 
NPEC Governance Committee. Members of 
this committee represent a diverse range 
of key stakeholders from maternity units 
and universities throughout the country 
(Appendix D).
Lastly, I would like to thank the staff of 
the NPEC (Appendix E) for their work and 
dedication to the mission of the Centre, 
in translating clinical audit data and 
epidemiological evidence to inform maternity 
services for families in Ireland.
Richard A Greene, Director, NPEC
National Perinatal Epidemiology Centre
5th Floor, Cork University Maternity Hospital
Wilton, Cork, Ireland
Email: npec@ucc.ie
Tel: +353 (21) 420 5017
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Executive summary
This is the second report from the national 
audit of severe maternal morbidity (SMM) in 
Ireland. It reports on 615 cases of SMM that 
occurred in maternity units in 2012 and 2013. 
There were 292 cases in 2012 notified by 
nineteen of the country’s 20 maternity units 
and 323 cases notified for 2013 when all 20 
units participated.
Over the three years of this audit, the reported 
incidence of SMM in Irish maternity units 
increased from 3.83 per 1,000 maternities 
in 2011 to 4.44 per 1,000 in 2012 and 4.75 
per 1,000 in 2013, suggesting an upward 
trend in SMM. Despite this, the incidence of 
SMM in Ireland compares favourably with 
the rate reported from the methodologically 
comparable national audit in Scottish 
maternity units (SCASMM) over similar years. 
The most recently reported Scottish SMM rate 
is 7.3 per 1,000 maternities for 2012.
The majority of the women (70%) who 
experienced SMM in 2012 and 2013 were 
diagnosed with one SMM, one in four (24%) 
were diagnosed with two severe morbidities, 
6% with three and 1% of the women were 
diagnosed with four morbidities.
Similar to findings in the Scottish audit, major 
obstetric haemorrhage (MOH) was the most 
frequently reported SMM (55%). The next 
most common reportable SMM events were 
admission to intensive care unit or coronary 
care unit (ICU/CCU; 42%), renal or liver 
dysfunction (7%), peripartum hysterectomy 
(7%) and pulmonary embolism (6%).
The 341 reported MOH cases gave an 
incidence rate of 2.55 per 1,000 maternities in 
2012/2013, less than half the equivalent rate 
in Scotland for the same years. Uterine atony 
was the most common underlying cause 
(38%) of MOH followed by retained placenta/
membranes (17%). This mirrors findings 
from successive SCASMM reports. The vast 
majority of MOH cases (84%) occurred during 
or after birth, 18% occurred in the intrapartum 
period and two thirds in the postpartum 
period. Almost all women who experienced 
MOH (93%) received a blood transfusion. 
Admission into an ICU/CCU has been used 
as a marker for SMM internationally and is 
a reportable event in this audit. MOH was 
associated with 41% of the 261 ICU/CCU 
admissions reported for 2012/2013. However, 
an increasing proportion of reported ICU/CCU 
cases had no other associated SMM as defined 
in this audit (25% in 2011, 35% in 2012 and 
41% in 2013). Our discussions with the units 
suggests such ICU/CCU admissions reflect 
resource issues in maternity units when 
women need a higher level of monitoring. This 
finding is one of the motivations for the new 
NPEC Audit of Critical Care in Obstetrics in 
Ireland which is currently being implemented 
in maternity units across the country.
There were 42 reported cases of peripartum 
hysterectomy (PH) in 2012 and 2013 giving a 
national rate of 0.31 per 1,000 maternities or 
approximately one in every 3,200 maternities. 
This PH rate is similar to national rates 
reported in the UK and the Netherlands of 0.41 
and 0.33 per 1,000 births respectively. The 
majority of PH cases (81%) were associated 
with MOH. Eighty percent of all women 
who required PH had a previous caesarean 
section and for most of these cases morbidly 
adherent placenta was a causal factor for 
PH. This adds to the growing evidence of an 
association between previous caesarean 
section, morbidly adherent placenta and 
PH and suggests that if caesarean section 
rates continue to increase there may be an 
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associated increase in the rate of PH. Over 
half (54.8%) of the women who required a PH 
were admitted to ICU which also indicates that 
resources required to manage these women 
extend well beyond surgical costs.
Recent reports on maternal mortality in Ireland 
and the UK have identified that thrombosis 
and thromboembolism as a leading cause 
of maternal deaths due to direct obstetric 
causes. 
The incidence of pulmonary embolism (PE) 
reported in this audit in 2012/2013 was 0.27 
per 1,000 maternities or one in 3,700 women. 
Notwithstanding the small numbers involved, 
this audit also identified that the risk of PE in 
cases of peripartum hysterectomy (95 per 
1,000 maternities or approximately one in ten 
maternities) is several hundred times greater 
than the risk in all maternities.
While the number of cases was small, there 
were sixteen cases of septic shock reported 
for 2013 in contrast to four reported cases 
in each of the two preceding years. This may 
be a true increase in incidence or may be 
associated with an increased awareness and 
recognition of sepsis.
The perinatal mortality rate (PMR) among 
infants born to women who experienced SMM 
was 51.5 per 1,000 births, i.e. one in 20 of the 
infants died. This is eight times the perinatal 
mortality rate observed for all births in Ireland.
Multiple pregnancy was associated with a 
more than fourfold increased risk of SMM. 
The SMM rate was 4.4 per 1,000 maternities 
associated with singleton pregnancy in 
2013 and was 20.7 per 1,000 maternities for 
multiple pregnancy.
The mode of delivery for two thirds of the 
women who experienced SMM was caesarean 
section. While this is over twice the caesarean 
section rate for all births nationally, the 
majority of caesarean sections in cases of 
SMM were carried out prior to labour which 
may reflect the clinical complexity of the 
pregnancy rather than mode of delivery 
influencing risk of SMM.
Variation in rates of SMM and MOH were 
identified between units. However, differences 
between units must be interpreted with 
caution, as they are likely related to 
differences in the risk profile of the pregnant 
women presenting to the units rather than the 
care given.
The association between maternal age and 
risk of SMM followed a J-shaped curve. 
The lowest SMM rate, at 3.1 per 1,000, was 
among women aged 20-24 years. The rate 
was marginally higher for younger women. 
Otherwise, the SMM rate increased with 
increasing maternal age. Respectively, 35-39 
year-olds and women over 40 years of age 
had almost twice and three times the SMM 
rate of 20-24 year-olds.
Women with higher parity, i.e. para 3+, were 
overrepresented among SMM cases compared 
to the general pregnant population.
There was evidence that being of non-
caucasian ethnicity was linked to increased 
risk of SMM. However, assessment of the 
association between maternal characteristics, 
such as body mass index, smoking and socio-
economic status, and risk of SMM is hampered 
by the lack of available national data for the 
population of pregnant women in Ireland.
The detailed MOH audit identified trends in 
management and monitoring of cases over 
the three years of the MOH audit. There was an 
increase in the presence of obstetric consultants, 
senior midwives and anaesthetic consultants 
attending cases of MOH in later years. This may 
be in response to the national guideline which 
recommends a multidisciplinary care approach 
with early direct consultant and senior staff 
involvement in the management of postpartum 
haemorrhage. However, in cases identified as 
high risk in the antenatal period due to known 
or suspected morbidly adherent placenta, there 
was a decrease in the reported presence of a 
consultant obstetrician at delivery.
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In almost all MOH cases (98.8%) it was 
stated that the unit had a protocol for the 
management of MOH and management of 
the MOH adhered to the protocol in 87.5% of 
cases. Quality of care as self-assessed by 
reporting units in cases of MOH was reported 
as appropriate in the vast majority (85.6%) of 
cases. For a small proportion of cases (2.9%) 
it was reported that management of the case 
was suboptimal impacting on the adverse 
outcome. It must be acknowledged that these 
findings are based on unit self-assessment.
The use of obstetric early warning charts in 
the monitoring of patients was reported in 
75% of MOH cases in 2012/2013, a marked 
increase on the 45% reported rate of their use 
for MOH cases in 2011. This is likely related 
to the development and lead up to the full 
implementation of the national Irish Maternity 
Early Warning System (IMEWS) in 2014.
In summary, the findings of this national SMM 
audit highlight the clear need for on-going 
prospective audit in order to identify adverse 
maternal outcomes. Although SMM may reflect 
the complexity of the pregnant population, it 
also acts as a surrogate measure of quality of 
care in the maternity services. The findings 
from the detailed MOH audit, carried out for 
the years 2011-2013, suggest good practice 
in terms of the care provided including the 
involvement of senior multidisciplinary staff 
and appropriate monitoring and treatments. 
Further audit of adverse maternal outcomes 
can guide clinical practice and inform 
prospective counselling of women at high risk 
of severe maternal morbidity.
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Recommendations
•	 While	 outcomes	 are	 positive	 with	 regard	 to	 the	
management of major obstetric haemorrhage 
described in this report and acknowledging the 
publication in 2012 of the national clinical practice 
guideline on primary postpartum haemorrhage, 
there may be value in developing national guidance 
on antepartum haemorrhage and on management of 
abnormally adherent placenta.
•	 Collation	of	an	agreed	national	dataset	from	maternity	
services needs to be made possible in order to 
facilitate examination of factors influencing obstetric 
outcomes including severe maternal morbidity. This 
may be achieved through the implementation of the 
Maternal Newborn - Clinical Management System.
•	 While	 available	 in	 some	 units,	 formal	 counselling	
support should be available for all women and their 
partners following a severe maternal morbidity 
across all units in Ireland.
•	 Variances	 between	 units	 in	 intensive	 care	 unit	
admission rates warrant further investigation. This 
is a focus of the new NPEC Audit of Critical Care in 
Obstetrics in Ireland, which, with the support of 
colleagues in the maternity services will establish 
resource needs in levels of care and lead to better 
service provision.
•	 The	NPEC	Maternal	Morbidity	Advisory	Group	endorses	
the national clinical programme’s multidisciplinary 
training in the management of postpartum 
haemorrhage. We recommend the development and 
national implementation of a specific proforma to 
improve management and documentation during a 
major obstetric haemorrhage event whether in the 
antenatal or postnatal period. An example of such a 
proforma is included in Appendix F.
•	 A	 quantitative	 approach	 involving	 volume	 and	
weight assessment to estimate blood loss should be 
considered for use in all maternity units. Development 
of a national toolkit would assist standardisation of 
such an approach.
•	 For	women	at	expected	high	 risk	of	major	obstetric	
haemorrhage, clear plans should be included in 
the maternity healthcare record and consideration 
should be given to the use of interventional radiology. 
The feasibility of providing such a service in all health 
service regions should be assessed.
•	 Robust	 clinical	 audit	 of	 perinatal	 outcomes	 in	 all	
maternity units in Ireland is vital for patient care. Such 
audit requires the protected time of clinical staff. 
Funding should be provided by the Health Service 
Executive (HSE) to ensure that staffing levels allow 
protected time for clinical audit.
•	 All	 maternity	 units	 should	 continue	 to	 collect	
and submit data on severe maternal morbidity to 
inform the maternity services through the NPEC 
national audit on severe maternal morbidity. A 
multidisciplinary approach, involving consultant 
obstetricians, consultant anaesthetists, senior 
midwives and senior trainees is recommended to 
ensure complete case ascertainment. The NPEC is 
aware that some units find regular multidisciplinary 
meetings assist this.
Based on the findings of this report, the NPEC makes the following 
recommendations:
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Data recording
There were 20 maternity units in Ireland 
in 2012 and 2013. Nineteen of the units 
contributed data to this audit for 2012 
and all 20 units contributed for 2013. The 
individual contributors and co-ordinators for 
the audit within each participating maternity 
unit are listed in Appendix C. These are 
designated midwives, obstetric consultants 
or specialist registrars who complete the 
NPEC Severe Maternal Morbidity Notification 
Form (Appendix G). This is a validated data 
collection tool originally designed for the 
Scottish Confidential Audit of Severe Maternal 
Morbidity. The form was adapted for the Irish 
setting and contains minimal information on 
maternal and delivery characteristics.
For this audit, a case of severe maternal 
morbidity (SMM) was defined as a 
pregnant or recently-pregnant woman 
who experienced any of the following 
seventeen maternal morbidities in 2012 
and 2013: major obstetric haemorrhage, 
uterine rupture, peripartum hysterectomy, 
eclampsia, renal or liver dysfunction, 
pulmonary oedema, acute respiratory 
dysfunction, pulmonary embolism, cardiac 
arrest, coma, cerebrovascular event, status 
epilepticus, septicaemic shock, anaesthetic 
complications, admission to an intensive care 
or coronary care unit, interventional radiology 
and other severe morbidity. Definitions for 
these morbidities are provided at the end of 
the Notification Form.
The other severe morbidity category was 
included to explore whether further specific 
morbidities warrant inclusion in the audit. 
Findings are not provided in this report for 
cases in this category unless one of the other 
specified morbidities was also experienced.
For 2012 and 2013, uterine rupture was a 
specified morbidity for the audit whereas this 
was not the case for 2011, the first year of the 
audit. This change has led to a small increase 
in reportable cases of SMM. However, most 
cases of uterine rupture meet the criteria 
for major obstetric haemorrhage and were 
therefore reported in all three years of the 
audit.
In the case of major obstetric haemorrhage 
(defined as blood loss of at least 2,500ml, 
transfusion of five or more units of blood or 
documented treatment for coagulopathy), 
participating units were asked to complete an 
additional detailed case assessment form. The 
NPEC Severe Maternal Morbidity Notification 
Form and the Major Obstetric Haemorrhage 
Form are available for download on the NPEC 
website (http://www.ucc.ie/en/npec/npec-
clinical-audits/).
Denominator data on the number of maternities 
were provided directly by individual maternity 
units. The denominator underestimates the 
number of women at risk of SMM as it does 
not include miscarriage, ectopic pregnancy 
and molar pregnancy, which may be reported 
as cases of SMM and thereby included in 
the numerator. However, complete data on 
maternities resulting in miscarriage, ectopic 
pregnancy and molar pregnancy are not 
available and therefore, to ensure uniformity, 
the denominator was restricted to live 
births and stillbirths of babies weighing at 
least 500g. The approach of not including 
miscarriage, ectopic pregnancy and molar 
pregnancy in the denominator is also the 
approach taken by the Scottish Confidential 
Audit of Severe Maternal Morbidity.
Methods
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Data analysis
In keeping with the international published 
literature in this area, the incidence rate of 
SMM and of specific morbidities are calculated 
per 1,000 maternities resulting in the live 
birth or stillbirth of a baby weighing at least 
500g. For incidence rates 95% confidence 
intervals were calculated using the Normal 
approximation of a binomial proportion 
confidence interval.
Funnel plots are used to illustrate both 
the variation in incidence rates across 
participating maternity units and the 
deviation of the rate for each individual unit 
from the national rate. The national rate is 
plotted as a straight line. A 95% confidence 
interval for the national rate is plotted using 
a dashed line. The width of the confidence 
interval is adjusted to allow for meaningful 
comparison between unit-specific rates and 
the national rate. The confidence interval is 
wider for smaller units reflecting the lack of 
precision in rates calculated based on small 
numbers. The confidence interval narrows 
for larger maternity units, giving the diagram 
a ‘funnel’ shape. Maternity unit rates outside 
the 95% confidence interval are statistically 
significantly different from the national rate. 
In general, one in 20 units would be expected 
to lie outside the 95% confidence interval by 
chance alone.
Some of the variation in rates across maternity 
units will be due to differences in the profile 
of the women attending the maternity units. 
Data are not available to allow for adjustment 
of the profile of women attending the 
country’s maternity units. For this reason, 
we recommend conservative interpretation 
of differences between the rates of units and 
their deviation from the national rate.
Further analysis was conducted to assess 
variation in incidence rates between years, 
maternal age groups, single and multiple 
pregnancies and between Ireland and 
Scotland. This analysis involved using Poisson 
regression which calculates a rate ratio (for 
example, the rate in one year divided by the 
rate in the previous year). Rate ratios have 
the advantage of being easy to interpret. A 
rate ratio is greater than one if a rate is greater 
than the rate to which it is being compared. 
For example a rate ratio of 1.25 indicates 
the rate being examined is 25% higher than 
(or 1.25 times) the rate to which it is being 
compared. Conversely, a rate ratio will be 
less than one if a rate is less than the rate 
to which it is being compared. For example a 
rate ratio of 0.80 indicates that the rate being 
examined is equivalent to 80% of the rate to 
which it is being compared, i.e. it is 20% lower. 
The Poisson regression analysis provides 
a 95% confidence interval for the rate ratio 
and the associated p-value, both of which 
indicate whether the rate difference is in line 
with what might be expected due to chance. 
A rate difference is considered to be beyond 
what might be expected by chance, i.e. 
statistically significant, if the 95% confidence 
interval for the rate ratio does not include the 
value one. This is equivalent to the p-value 
derived from the analysis being less than 
0.05. If the p-value is less than 0.001 then 




The nineteen participating maternity units 
reported that 292 women experienced severe 
maternal morbidity (SMM) in 2012, as defined 
in this audit. For 2013, all 20 maternity units in 
the country participated and reported that 323 
women experienced SMM. Thus, 615 women 
were reported as experiencing SMM in the two 
years. Table 1 details the number of cases, total 
maternities and SMM rates for the three years of 
this audit, 2011-2013.
From 2011 to 2013, the SMM rate varied from 
3.83 to 4.75 per 1,000 maternities or from one 
in 260 maternities to one in 210 maternities. 
Respectively, the SMM rate was 16%, 24% and 
20% higher in 2012, 2013 and 2012/13 than the 
base year 2011. This is equivalent to an annual 
rate increase of 11% (annual rate ratio=1.11, 95% 
CI=1.02-1.20, p-value=0.011). While three years 
is too short a time period to establish trends, this 
extent of increase is beyond expected yearly 
variation and this was also the conclusion of an 
analysis that excluded cases of uterine rupture 
exclusive of MOH reported in 2012 (n=9) and 
2013 (n=6), cases that were not reported to 
the audit in 2011. However, the increase may be 
associated with improved case ascertainment 
over these first years of the audit.
The most recent data from the methodologically 
comparable national audit in Scotland reported 
an SMM rate of 7.3 per 1,000 maternities for 2012. 
The Irish SMM rate for the same year is almost 
40% lower than the Scottish rate (rate ratio=0.61, 
95% CI=0.52-0.71, p-value<0.001).
National rate
Table 1: Incidence of severe maternal morbidity (SMM) in Ireland, 2011-2013
Note: 95% CI=95% confidence interval. * Cases of uterine rupture exclusive of major obstetric haemorrhage were not reported for 2011.
 2011* 2012 2013 2012/13
Maternities in participating units 67,806 65,768 68,047 133,815
SMM cases 260 292 323 615
SMM rate 3.83 4.44 4.75 4.60
(95% CI) (3.36-4.31) (3.92-4.96) (4.22-5.27) (4.23-4.96)
Rate ratio 1.00 1.16 1.24 1.20
(95% CI) (Ref.) (0.98-1.37) (1.05-1.46) (1.04-1.39)
p-value  0.086 0.011 0.014
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Approximately 70% of the women (n=425, 
69.1%) who experienced SMM in 2012 and 
2013 were diagnosed with one SMM, one in 
four (n=149, 24.2%) were diagnosed with 
two severe morbidities, 6% (n=35, 5.7%) with 
three and 1% of the women (n=6, 1.0%) were 
diagnosed with four morbidities.
Major obstetric haemorrhage (MOH) was 
the most frequently reported event, being 
involved in over half of the SMM cases each 
year (Table 2). The incidence of MOH was 
2.55 per 1,000 maternities in 2012/13. The 
equivalent incidence of MOH in Scotland for 
2012 was 5.8 per 1,000 maternities (95% 
CI=5.2-6.5), more than twice the Irish rate.
The national audit in Scotland showed that 
their increasing incidence of SMM over the past 
decade was due to an increase in MOH. The NPEC 
previously showed that Ireland experienced an 
increasing trend in postpartum haemorrhage 
between the years 1999 to 2009.2 An increasing 
number of MOH cases has been reported to 
this audit over the three-year period 2011-2013 
(Table 2). The incidence of MOH cases increased 
from 2.34 per 1,000 maternities in 2011 to 2.49 
per 1,000 in 2012 and 2.60 per 1,000 in 2013, 
an overall increase of 11% (rate ratio=1.11, 
95% CI=0.90-1.37, p-value=0.344), which is 
not beyond what might be expected in yearly 
variation for rates of such magnitude.
Table 2: Incidence of specific severe maternal morbidities (SMMs) in Ireland, 2011-2013
 2011 2012 2013 2012/13 Rate(95% CI)
 n n n n (%)
Major obstetric haemorrhage (MOH) 159 164 177 341(55.4) 2.55(2.27-2.82)
ICU/coronary care unit admission 111 130 131 261(42.4) 1.95(1.71-2.19)
Renal or liver dysfunction  26 22 21 43(7.0) 0.32(0.22-0.42)
Peripartum hysterectomy 23 22 20 42(6.8) 0.31(0.22-0.41)
Pulmonary embolism  12 18 18 36(5.9) 0.27(0.18-0.36)
Eclampsia  12 8 16 24(3.9) 0.18(0.11-0.25)
Uterine rupture NR 14 10 24(3.9) 0.18(0.11-0.25)
Pulmonary oedema  8 11 10 21(3.4) 0.16(0.09-0.23)
Septicaemic shock  4 4 16 20(3.3) 0.15(0.08-0.22)
Acute respiratory dysfunction  5 3 6 9(1.5) 0.07(0.02-0.11)
Cardiac arrest  7 7 1 8(1.3) 0.06(0.02-0.10)
Anaesthetic problem  7 5 3 8(1.3) 0.06(0.02-0.10)
Interventional radiology 16 3 5 8(1.3) 0.06(0.02-0.10)
Cerebrovascular event  6 4 3 7(1.1) 0.05(0.01-0.09)
Status epilepticus  3 0 0 0(0.0) 0(0-0)
Coma 0 0 0 0(0.0) 0(0-0)
Total women affected 260 292 323 615(100) 4.60(4.23-4.96)
Note: n represents number of women affected by the specific morbidity; % is based on the total number of SMM cases in 2012/13; rate is per 
1,000 maternities in 2012/13; 95% CI=95% confidence interval; ICU=intensive care unit; NR=not recorded by the audit in 2011 unless associated 
with MOH.
Specific morbidities
2 Lutomski J et al. Increasing trends in atonic postpartum haemorrhage in Ireland: an 11-year population-based cohort study. BJOG 2012; 119: 306-14.
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The incidence of Irish SMM cases not involving 
MOH has increased more notably by 44% during 
2011-2013 (rate ratio=1.44, 95% CI=1.12-1.86, 
p-value=0.005). There were 101 such cases 
reported for 2011 (rate=1.49, 95% CI=1.19-1.79 per 
1,000 maternities), 128 cases for 2012 (rate=1.95, 
95% CI=1.60-2.29 per 1,000 maternities) and 146 
cases for 2013 (rate=2.14, 95% CI=1.79-2.50 per 
1,000 maternities).
Most other specific morbidities were reported in less 
than 10% of the SMM cases (Table 2). There were 42 
reported cases of peripartum hysterectomy (PH) 
in 2012 and 2013 giving a national rate of 0.31 per 
1,000 maternities or approximately one in every 
3,200 maternities. This PH rate is similar to national 
rates reported in the UK and the Netherlands of 
0.41 and 0.33 per 1,000 births respectively. An 
indepth description of these cases of PH is provided 
later in this Report.
Recent reports on maternal mortality in 
Ireland and the UK have identified thrombosis/
thromboembolism as a leading direct obstetric 
cause of maternal death. The incidence of 
pulmonary embolism (PE) reported in this audit in 
2012/2013 was 0.27 per 1,000 maternities or one 
in 3,700 women.
While the number of cases was small, there were 
sixteen cases of septic shock reported for 2013 in 
contrast to four reported cases in each of the two 
preceding years. This may be a true increase in 
incidence or may be associated with an increased 
awareness and recognition of sepsis.
As an internationally-recognised marker for SMM, 
admission into an intensive care unit or coronary 
care unit (ICU/CCU) was a reportable event in this 
audit and occurred for 42% of the SMM cases in 
2012/13 (n=261). Table 3 details the specific SMMs 
involved in the 261 cases admitted into an ICU/CCU. 
Approximately 40% of these cases involved MOH, 
9% involved peripartum hysterectomy and 6% 
involved renal or liver dysfunction.
In 2012 and 2013 a high proportion of women 
admitted into ICU/CCU (38%, n=99 of 261) had not 
experienced a severe morbidity as defined in this 
audit. This phenomenon has increased over the 
three years of the audit. In 2011, 2012 and 2013, 
the proportion of cases admitted to an ICU/CCU 
with no associated severe morbidity was 25%, 
35% and 41%, respectively (2011: n=28 of 111, 
25.2%; 2012: n=46 of 130, 35.4%; 2013: n=53 of 
131, 40.5%).For the years 2012 and 2013 almost 
half (n=45) of these cases occurred in two 
small maternity units with on-site ICU facilities. 
Feedback from these units indicated that the rate 
of such ICU/CCU admissions reflected resource 
issues in terms of staffing levels and high 
dependency facilities when women needed a 
higher level of monitoring. This is evidence of safe 
practice for these particular units.
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Table 3: Specific severe maternal morbidities (SMMs) associated with admission to an intensive 
care unit or coronary care unit (ICU/CCU) in Ireland, 2012/13
 n(%) 
Major obstetric haemorrhage (MOH) 108(41.4)
Peripartum hysterectomy 23(8.8)
Renal or liver dysfunction 15(5.7)
Pulmonary embolism  10(3.8)
Eclampsia  9(3.4)
Pulmonary oedema  8(3.1)
Septicaemic shock  7(2.7)
Uterine rupture 6(2.3)
Acute respiratory dysfunction  6(2.3)
Cardiac arrest  5(1.9)
Cerebrovascular event  4(1.5)
Interventional radiology 2(0.8)
Anaesthetic problem  1(0.4)
None of the above 99(37.9)
Total women admitted to ICU/CCU 261(100)
Note: n represents number of women affected by the specific morbidity; % is based on the total number of women admitted 
to ICU/CCU in 2012/13.
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Number of maternities in 2012 and 2013 
Unit SMM rate National SMM rate 95% CI 
Variation in the 2012/13 SMM rate across 
Ireland’s 20 maternity units is illustrated in the 
funnel plot in Figure 1. The solid line represents 
the national SMM rate (4.60 per 1,000 
maternities). The dashed lines represent the 
limits of the 95% confidence interval around 
the national rate. These limits are adjusted 
according to the number of maternities at each 
unit and are wider for smaller units reflecting 
the greater volatility in rates based on small 
numbers. In applying 95% confidence limits, 
we can expect, on average, one of the twenty 
units to have a rate outside the dashed lines. 
However, differences between units must 
be interpreted with caution, as they may not 
reflect care given but could reflect differences 
in levels of reporting and/or differences in the 
risk profile of the pregnant women presenting 
to the units.
Variation in rates by maternity unit
From Figure 1 it can be seen that two units 
have outlying SMM rates, one with a rate far 
below the lower limit of the confidence interval 
and another with a rate far beyond the upper 
limit. The NPEC is working with the former unit 
to review case ascertainment. Analysis of 
the SMM cases from the unit with the highest 
rate showed that the majority were reported 
because they met the SMM criterion of being 
admitted to an ICU/CCU with no other SMM 
experienced as defined in this audit. These 
are patients requiring monitoring above 
normal ward standard and due to low levels of 
staff in this unit, this could only be achieved 
by admission to the ICU. This is evidence of 
good practice in prioritising patient safety in 
the context of constrained staffing levels. This 
unit is working to address this situation with 
an evolving business plan.
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Number of maternities in 2012 and 2013 
Unit MOH rate National MOH rate 95% CI 
Figure 2 illustrates variation in the rate of MOH 
across the 20 maternity units in the country in 
2012/13. A small number of units are outside 
the limits of the confidence interval for the 
rate although by a relatively small margin. 
Analysis of the data suggested that this may 
reflect variation across units in the method 
used to estimate blood loss.
 21
 Age group SMM SMM SMM All maternities SMM rate Rate ratio
  2012 2013 2012/13 2013 2013 (95% CI)
  (N=283) (N=319) (N=602)  (95% CI)
 <20yrs 3(1.0) 6(1.9) 9(1.5) 2.0% 4.35 1.39
      (0.81-7.90) (0.56-3.46)
 20-24yrs 14(4.8) 20(6.2) 34(5.5) 9.4% 3.14 1.00
      (1.74-4.54) (Ref.)
 25-29yrs 60(20.5) 44(13.6) 104(16.9) 20.3% 3.19 1.02
      (2.23-4.16) (0.60-1.73)
 30-34yrs 88(30.1) 118(36.5) 206(33.5) 36.7% 4.73 1.51
      (3.86-5.59) (0.94-2.42)
 35-39yrs 97(33.2) 100(31.0) 197(32.0) 25.8% 5.70 1.82
      (4.56-6.83) (1.12-2.94)
 ≥40yrs 30(10.3) 35(10.8) 65(10.6) 5.7% 8.97 2.86
      (5.95-11.99) (1.65-4.96)
Note: Values are shown as n(%) unless otherwise stated. Data for all maternities are from Perinatal Statistics Report 2013. 
Healthcare Pricing Office (HPO). Dublin: HPO, 2014. SMM rate per 1,000 maternities.
Table 4: Age distribution of women who experienced severe maternal morbidity (SMM) in 2012 and 2013
Age
Maternal age for the 615 cases of severe 
maternal morbidity (SMM) in 2012 and 2013 
ranged from 16 to 48 years. The average age 
was 33 years in each year (Standard deviation 
= 6 years). The age distribution of women 
who experienced SMM in 2012 and 2013 is 
detailed in Table 4. Just over 60% were aged 
30-39 years which was also the case for the 
population of women who gave birth in 2013. 
However, there was evidence of an increased 
risk of SMM among women aged at least 35 
years as they were overrepresented in the 
audit. Women in this age range accounted for 
42% of SMM cases in 2013 compared to 32% of 
the population who gave birth that year.
This is reflected in the SMM rate calculated 
by maternal age based on data for 2013 
(Table 4), which followed a J-shaped curve. 
The lowest SMM rate, at 3.1 per 1,000 births 
was associated with women aged 20-24 
years. The rate was marginally higher for 
women aged under 20 years. Otherwise, 
the SMM rate increased with increasing 
maternal age. Respectively, 35-39 year-olds 
and women over 40 years of age had almost 
twice (p-value=0.015) and three times 
(p-value<0.001) the SMM rate of 20-24 year-
olds.
Maternal characteristics
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Ethnicity
There are no national data available on 
ethnicity for the pregnant population in 
Ireland. The distribution by ethnic group of 
the women who experienced SMM in 2012/13 
closely reflected that of the general population 
of women aged 15-49 years as reported from 
the most recent national census (Table 5). 
Three-quarters were of white Irish ethnicity, 
a little lower than the 80% reported as white 
Irish by the census.3 In those who experienced 
SMM there was an overrepresentation of 
women whose ethnicity was described as 
Black/ Black Irish. This group made up 7% of 
SMM cases but only 1.6% of the population 
aged 15-49 years.
Body mass index
Body mass index (BMI) for the women who 
experienced SMM in 2012 and 2013 ranged 
from 16 to 56kgm-2. BMI was not known for 
78 (13%) of the women. This indicates an 
improvement in reporting as BMI was not 
known for 29% of reported SMM cases in 2011. 
Less than half of the women who experienced 
SMM had a BMI in the healthy range, 30% were 
overweight and one in four were obese (Table 
6). This BMI profile closely matches that of 
the women in the 2007 Survey of Lifestyle, 
Attitudes and Nutrition (SLÁN).4 However, 
interpretation of this comparison must 
consider the weight gain due to pregnancy 
for the women who experienced SMM and 
the fact that the SMM and SLAN data are not 
coterminous. However, there are no national 
data available on BMI for the pregnant 
population.
 SMM 15-49 year-old
 2012/13 female population, 2011
 (N=615) % 
White Irish 454(73.8) 80.4
Irish Traveller 4(0.7) 0.7
Other white background 71(11.5) 12.5
Asian/Asian Irish 35(5.7) 2.4
Black/Black Irish 43(7.0) 1.6
Other/mixed 1(0.2) 1.0
Not recorded 7(1.1) 1.4
BMI category (kgm-2) SMM SLAN
 2012/13 2007
 (N=537)* % 
Underweight (<18.5) 10(1.9) 2
Healthy (18.5-24.9) 237(44.1) 44
Overweight (25.0-29.9) 160(29.8) 31
Obese (≥30.0) 130(24.2) 23
Note: Values are shown as n(%) unless otherwise stated.
Note: SLAN=Survey of Lifestyle, Attitudes and Nutrition. Values are shown as n(%) unless otherwise stated. * BMI was not 
known for 78 women.
Table 5: Ethnicity of women who experienced severe maternal morbidity (SMM) in 2012 and 2013
Table 6: Body mass index (BMI) of women who experienced severe maternal morbidity (SMM) in 
2012 and 2013
3 Central Statistics Office. Profile 7 Religion, Ethnicity and Irish Travellers. 2012. Dublin: The Stationary Office. 
4 Harrington J, Perry I, Lutomski J, Morgan K, McGee H, Shelley E, Watson D, Barry M. Survey of Lifestyle, Attitudes and Nutrition 
in Ireland: Dietary Habits of the Irish population. 2008. Dublin: The Stationary Office.
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Smoking, alcohol and drug misuse
Smoking status at the time of the first hospital 
booking appointment was not known for 9% of 
the women (n=58, 9.4%). Of the remainder, one 
in nine were reported to have been smoking 
(Table 7). The prevalence of smoking during 
pregnancy is not routinely known for all Irish 
pregnancies but rates of 12%, 15%, 16% and 
19% have been reported for England, Northern 
Ireland, Wales and Scotland, respectively.5
The quantity being smoked was recorded 
for 53 of the 64 smokers in this audit. On 
average, they were smoking 11 cigarettes per 
day though one in four (n=13, 24.5%) were 
reported to be smoking 20 cigarettes per day. 
Ten women were reported to have given up 
smoking during their pregnancy, three before 
and seven after their first hospital booking 
appointment.
Previous pregnancy
Approximately 40% of the women who 
experienced SMM in 2012 and 2013 were 
nulliparous which is in line with the population 
of maternities in Ireland (Table 8).
There was an overrepresentation of women 
of higher parity, i.e. para 3+, among the SMM 
cases compared with the overall population 
(14% vs. 9%). As a corollary, 30% of the SMM 
cases were para 1 compared to 35% of the 
national population of women giving birth.
 2012 2013 2012/13
 (N=273)* (N=284)* (N=557)*
Smoking 32(11.7) 32(11.3) 64(11.5)
Note: Values are shown as n(%) unless otherwise stated. * Smoking status was not known for 58 women.
Table 7: Smoking status at time of first hospital booking for women who experienced severe 
maternal morbidity in 2012 and 2013
Alcohol drinking status at the time of the first 
hospital booking appointment was not known 
for 41% of the women (n=252, 41.0%). Of the 
363 women with available data, only 6% were 
reported to be drinking alcohol (n=23, 6.3%). 
Seven women (1.2%) were recorded as having 
a documented history of drug abuse.
5 EURO-PERISTAT Project with SCPE and EUROCAT. European Perinatal Health Report. The health and care of pregnant women 
and babies in Europe in 2010. May 2013. Available www.europeristat.com
Parity SMM  SMM SMM All maternities
 2012 2013 2012/13 2013
 (N=288)* (N=321)* (N=609)* 
Nulliparous 119(41.3) 122(38.0) 241(39.6) 38.4%
Para 1 88(30.6) 97(30.2) 185(30.4) 35.2%
Para 2 43(14.9) 55(17.1) 98(16.1) 17.4%
Para 3+ 38(13.2) 47(14.6) 85(14.0) 9.1%
Table 8: Distribution of parity for women who experienced severe maternal morbidity (SMM) in 
2012 and 2013
Note: Values are shown as n(%) unless otherwise stated; * Parity was not known for four cases in 2012 and two cases in 2013. 
Data for all maternities are from Perinatal Statistics Report 2013. Healthcare Pricing Office (HPO). Dublin: HPO, 2014
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6 Scottish Confidential Audit of Severe Maternal Morbidity: 9th Annual Report (2013). Available from:http://www.
healthcareimprovementscotland.org/our_work/reproductive,_maternal__child/programme_resources/scasmm.aspx
Gestation of pregnancy
Gestation at delivery or pregnancy end ranged 
from six to 42 weeks. For two thirds of the 
women affected, their pregnancy went full 
term (Table 9). For a further one in five their 
pregnancy ended at moderate to late pre-term 
gestation (32-36 weeks). For 4-5% of the women, 
the end of pregnancy occurred before 22 weeks 
gestation.
 2012 2013 2012/13
 (N=287)* (N=317)* (N=604)*
Pre-viable (<22wks) 15(5.2) 11(3.5) 26(4.3)
Extremely pre-term (22-27wks) 4(1.4) 15(4.7) 19(3.1)
Very pre-term (28-31wks) 22(7.7) 14(4.4) 36(6.0)
Moderate/late pre-term (32-36wks) 50(17.4) 73(23.0) 123(20.4)
Term (37-41wks) 192(66.9) 204(64.4) 396(65.6)
Post-term (42wks+) 4(1.4) 0(0.0) 4(0.7)
Table 9: Gestation at delivery or pregnancy end for women who experienced severe maternal 
morbidity in 2012 and 2013
Multiple pregnancy
Forty-six of the 615 women who experienced 
SMM in 2012 and 2013 had a multiple 
pregnancy (7.5%; Table 10). There were 45 
twin pregnancies and one triplet pregnancy. 
In Ireland in 2012 and 2013, multiple births 
made up 1.8% of all maternities (n=2,559 
of 138,661). Thus, multiple pregnancy was 
approximately four times more common in 
cases of SMM than in all maternities, a reflection 
of the increased risk of SMM associated with 
multiple pregnancy. This is evident from the 
national SMM rate of 4.4 per 1,000 maternities 
associated with singleton pregnancy in 2013 
and a more than four times higher rate of 20.7 
per 1,000 maternities for multiple pregnancy 
that year (p-value<0.001). These findings are 
similar to findings from Scotland where 6.4% 
of SMM cases with available data in 2012 were 
associated with twin pregnancies, four times 
higher than their proportion of twin births in 
2012 (1.5%).
Note: Values are shown as n(%) unless otherwise stated; * Gestation was not known for five cases in 2012 and six cases in 2013.
 SMM SMM SMM All SMM rate Rate ratio
 2012 2013 2012/13 maternities 2013 (95% CI)
 (N=292) (N=323) (N=615) 2013 (95% CI)
Singleton 273(93.5) 296(91.6) 569(92.5) 98.1% 4.44 1.00
     (3.97-4.92) (Ref.)
Multiple 19(6.5) 27(8.4) 46(7.5) 1.9% 20.74 4.67
     (13.85-27.62) (3.15-6.92)
Table 10: Singleton and multiple pregnancy for women who experienced severe maternal morbidity 
(SMM) in 2012 and 2013
Note: Data for all maternities are from Perinatal Statistics Report 2013. Healthcare Pricing Office. Dublin: HPO, 2014. Values are 
shown as n(%) unless otherwise stated. SMM rate per 1,000 maternities.
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Mode of delivery
The mode of delivery for two thirds of the women 
who experienced SMM was caesarean section 
(Table 11). This is over twice the caesarean 
section rate occurring in all births nationally 
in 2012 (29%). The majority of caesarean 
sections in cases of SMM were carried out 
prior to labour which may reflect the clinical 
complexity of the pregnancy rather than mode 
of delivery influencing risk of SMM. Almost one 
in three women had a vaginal delivery, usually 
spontaneously. The Other category relates 
to cases occurring before fetal viability and 
include miscarriages and laparotomy.
Neonatal outcomes
For the 615 women who experienced SMM 
in 2012 and 2013, a total of 633 babies were 
delivered. There were 542 singleton births, 44 
twin births and one birth of triplets. Information 
on neonatal outcome was available for 583 
(92.1%) of these infants. There were 18 
stillbirths, 12 early neonatal deaths and two 
late neonatal deaths. The perinatal mortality 
rate based on the 30 stillbirths and early 
neonatal deaths was 51.5 per 1,000 births, i.e. 
approximately 5% or one in 20 of the infants 
died. This rate was eight times the perinatal 
mortality rate observed for all births in Ireland 
in 2012 (p-value<0.001), the most recent year 
for which data are available (Table 12). However, 
the rate is in line with the perinatal mortality 
rate among infants born to women with SMM in 
Scotland in recent years, which ranged from 17 
to 64 per 1,000 maternities.6
  2012 2013 2012/13
  (N=291)* (N=321)* (N=612)*
Vaginal 82(28.2) 102(31.8) 184(30.1)
 Spontaneous 56(19.2) 73(22.7) 129(21.1)
 Assisted breech 2(0.7) 3(0.9) 5(0.8)
 Ventouse 10(3.4) 16(5) 26(4.2)
 Non-rotational forceps 14(4.8) 10(3.1) 24(3.9)
Caesarean section 193(66.3) 207(64.5) 400(65.4)
 Elective LSCS (no labour) 64(22) 59(18.4) 123(20.1)
 Elective LSCS (labour) 5(1.7) 5(1.6) 10(1.6)
 Emergency LSCS (no labour) 52(17.9) 77(24) 129(21.1)
 Emergency LSCS (labour) 71(24.4) 63(19.6) 134(21.9)
 Classical 1(0.3) 3(0.9) 4(0.7)
Other 16(5.5) 12(3.7) 28(4.6)
Note: Values shown are n(%) unless otherwise stated; * Mode of delivery was not known for one case in 2012 and two cases 
in 2013. For four of the 46 cases of multiple birth mode of delivery differed for the babies and the more complex mode of 
delivery was taken as the primary mode. LSCS=Lower segment caesarean section. Other relates to cases occurring before 
fetal viability and includes miscarriage and laparotomy.
Table 11: Primary mode of delivery for women who experienced severe maternal morbidity in 
2012 and 2013
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Case criteria
Eighty percent of the 341 MOH cases 
reported in 2012 and 2013 met the criterion 
of exceeding 2,500ml of blood loss, half met 
the criterion of receiving blood products as 
treatment for coagulopathy and 43% of cases 
were transfused five or more units of blood 
(Table 14). Comparison between 2012 and 
2013 indicated that the number of MOH cases 
meeting the blood loss and coagulopathy 
criteria increased in line with the overall 
increase in the total number of MOH cases 
reported whereas there was a drop in the 
number of cases transfused five or more units 
of blood.
Approximately 8% of infants were intubated 
following delivery and 39% were transferred to 
the Special Baby Care Unit (SBCU) or Neonatal 
Intensive Care Unit (NICU; Table 13). NICU 
transfer was required for almost two thirds of 
the twins compared to approximately one in 
three singletons.
Major obstetric haemorrhage
 Singletons Twins Triplets Total
 (N=542) (N=88) (N=3) (N=633)
Intubation following delivery (%) 42(7.7) 7(8.0) 0(0.0) 49(7.7)
Transfer to SBCU/NICU (%) 187(34.5) 54(61.4) 3(100.0) 244(38.5)
Table 13: Select neonatal outcomes by number of gestations
Note: SBCU=Special Baby Care Unit; NICU=Neonatal Intensive Care Unit.
 Perinatal deaths Births PMR Rate ratio
   (95% CI)  (95% CI)
All births 2012* 445 71755 6.2 1.0
   (5.6-6.8) (Ref.)
SMM 2012/2013 30 583 51.5 8.3
   (33.2-69.8) (5.7-12.0)
Table 12: Perinatal mortality among infants born to women with SMM in Ireland in 2012/2013 
compared to perinatal mortality among all infants born in Ireland in 2012
Note: PMR=perinatal mortality rate per 1,000 births; * Manning E, Corcoran P, Meaney S, Greene RA, on behalf of the Perinatal 
Mortality Group. Perinatal Mortality in Ireland Annual Report 2012. Cork: National Perinatal Epidemiology Centre, 2014.
 2012 2013 2012/13
 (N=163) (N=178) (N=341)
Estimated blood loss ≥ 2500ml 129(79.1) 144(80.9) 273(80.1)
Received blood products as treatment 
for coagulopathy 81(49.7) 94(52.8) 175(51.3) 
Transfused ≥ 5 units of blood 83(50.9) 65(36.5) 148(43.4)
Note: Values are shown as n(%) unless otherwise stated. Some cases met more than one criterion and therefore the 
percentages sum to more than 100%.
Table 14: Case criteria met for major obstetric haemorrhage in 2012 and 2013
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Table 15: Combinations of case criteria met for major obstetric haemorrhage in 2012 and 2013
 2012/13
 (N=341) 
Met one criterion 171(50.1)
 Estimated blood loss ≥ 2500ml 120(35.2)
 Received blood products as treatment for coagulopathy 35(10.3)
 Transfused ≥ 5 units of blood 16(4.7)
Met two criteria 85(24.9)
 Blood loss ≥ 2500ml and 
 received blood products for coagulopathy 38(11.1)
Blood loss ≥ 2500ml and transfused ≥ 5 units of blood 30(8.8)
 Received blood products for coagulopathy and 
 transfused ≥ 5 units of blood 17 (5.0)
Met all three criteria 85(24.9)
Note: Values are shown as n(%) unless otherwise stated
Sixteen women met the sole criterion of 
receiving a blood transfusion of at least five 
units and a further 30 women received such 
a transfusion in addition to experiencing 
blood loss of at least 2,500ml (Table 15). 
For these 46 women there was no reported 
receipt of coagulation factors. For significant 
transfusions in this setting, consideration 
should be given to transfusing coagulation 
factors including fibrinogen.7
Half of the MOH cases met one of the case 
criteria only (Table 15), usually the one 
related to blood loss. One in four cases met 
two criteria and again most of these cases 
involved an estimated blood loss exceeding 
2,500ml. In a further one in four cases, all 
three criteria were met.
Cause
Uterine atony was the most common cause 
of MOH (Table 16). It was associated with 
38% of the MOH cases, more than twice 
the percentage associated with the next 
most common cause, retained placenta / 
membranes. No cause was reported for five 
(1.5%) of the MOH cases. The frequency of 
the causes reported in 2012/2013 is very 
similar to that reported for 2011 cases of MOH 
when uterine atony and retained placenta/
membranes were associated with causing 
43% and 17% of MOH cases, respectively.
There was one reported cause for 70% (n=240, 
70.4%) of the 341 MOH cases in 2012/2013. 
Uterine atony was also most common in this 
regard, being the sole cause of one in five MOH 
cases (Table 16).
7 Royal College of Obstetricians and Gynaecologists. Prevention and management of postpartum haemorrhage. Green-top Guideline 
No. 52.London RCOG; 2009 [www.rcog.org.uk/globalassets/documents/guidelines/gt52postpartumhaemorrhage0411.pdf]
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  Sole cause Associated cause 
Uterine atony 72(21.1) 130(38.1)
Retained placenta/membranes 26(7.6) 58(17.0)
Bleeding from uterine incision 29(8.5) 49(14.4)
Placenta praevia 23(6.7) 44(12.9)
Abruption 19(5.6) 27(7.9)
Morbidly adherent placenta 6(1.8) 27(7.9)
Vaginal laceration 16(4.7) 25(7.3)
Uterine rupture 6(1.8) 8(2.3)
Cervical laceration 2(0.6) 5(1.5)
Broad ligament haematoma 1(0.3) 4(1.2)
Uterine inversion 1(0.3) 1(0.3)
Other specified cause 39(11.4) 66(19.4)
 Ruptured ectopic pregnancy 7(2.1) 7(2.1)
 Coagulopathy 3(0.9) 7(2.1)
 Uterine anomaly 2(0.6) 5(1.5)
Table 16: Reported causes of major obstetric haemorrhage in 2012 and 2013
Note: Values are shown as n(%) unless otherwise stated. Associated causes are not mutually exclusive and therefore 
percentages add up to over 100%.
Of the 341 women who experienced MOH in 
2012/2013, 221 were parous patients (para 
1+; 65.0%, data unknown for one case). 
History of previous caesarean section was 
known for 176 of these 221 women (79.6%). Of 
these, 35% had a previous caesarean section 





The number of previous caesarean sections 
appeared to influence the involvement of 
placenta praevia and/or morbidly adherent 
placenta as causes of MOH (Table 17). One 
or both were reported for 12% of MOH cases 
in women who had never had a previous 
caesarean section. They were cited as causing 
21% of MOH cases in women with one previous 
caesarean section and they were associated 
causes for most of the MOH cases in women 
with a history of two or more previous 
caesarean sections.
Number of previous  Placenta praevia and/or morbidly Total
caesarean sections adherent placenta reported as cause(s)
 Yes No 
0 9(11.7) 68(88.3) 77(43.8)
1 13(21.0) 49(79.0) 62(35.2)
≥2 22(59.5) 15(40.5) 37(21.0)
Total 44(25.0) 132(75.0) 176(100)
Note: Values are shown as n(%) unless otherwise stated; History of previous caesarean section was known for 176 of the 221 
women who had previously given birth.
Table 17: Placenta praevia and morbidly adherent placenta as causal factors of major obstetric 
haemorrhage by number of previous caesarean sections
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Onset and location
The vast majority of the reported MOH cases 
(n=282, 84%) occurred during or after birth 
– 18% intrapartum and two thirds in the 
postpartum period (Table 18). Four percent of 
cases occurred before 20 weeks gestations 
while one in eight occurred later in pregnancy 
but before birth.
Almost all cases of MOH occurred in obstetric-
led units (Table 19) which is to be expected 
considering that 84% of cases occurred during 
or after birth and almost all births in the 
country take place in obstetric-led units. In 
twelve cases of MOH, the woman was at home 
at the onset of haemorrhage. Most of these 
cases were antepartum (n=7, 58%) and none 
occurred intrapartum.
 2012 2013 2012/13
 (N=162)* (N=174)* (N=336)*
Early pregnancy (<20 weeks) 7(4.3) 5(2.9) 12(3.6)
Antepartum 17(10.5) 25(14.4) 42(12.5)
Intrapartum 31(19.1) 30(17.2) 61(18.2)
Postpartum 107(66.0) 114(65.5) 221(65.8)
 2012 2013 2012/13
 (N=143)* (N=135)* (N=278)*
Consultant-led unit 139(97.2) 127(94.1) 266(95.7)
At home 4(2.8) 8(5.9) 12(4.3)
Note: Values are shown as n(%) unless otherwise stated. * Timing of onset was not known for one case in 2012 and for four 
cases in 2013.
Note: Values are shown as n(%) unless otherwise stated. * Location of onset was not known for 20 cases in 2012 and for 43 
cases in 2013.
Table 18: Timing of onset of major obstetric haemorrhage in 2012 and 2013
Table 19: Location of onset of major obstetric haemorrhage in 2012 and 2013
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Mode of delivery
Caesarean section was the primary 
mode of delivery for 61% of the women 
who experienced MOH in 2012 and 2013 
(Table 20). This was the case for 67% of 
the women who experienced MOH in 2011. 
One in three women had a vaginal delivery and 
for the vast majority of these women it was 
spontaneous vaginal delivery. The category 
titled ‘other’ included instances of miscarriage 
and laparotomy related to cases where the 
gestational age was less than 22 weeks.
Mode of labour
Considering the 328 women who gave 
birth (119 by vaginal delivery and 209 by 
caesarean section; Table 20), the majority 
laboured (n=197, 60.1%). Onset of labour 
was spontaneous for most of these women 
(n=119, 62.0%) and was induced for 38% of 
cases (n=73, 38.0%; onset of labour unknown 
for five cases). This is higher than the average 
rate of induction of labour in Irish maternity 
units of 29% (based on data obtained from 13 
maternity units which accounted for 80% of 
maternities in Ireland in 2013) suggesting an 
increased risk of MOH following induction.
An increased risk of maternal morbidity has been 
associated with caesarean section performed 
at full cervical dilatation compared to caesarean 
section performed during the first stage of labour.8 
In this audit, an emergency caesarean section 
delivery at full cervical dilatation was reported for 
16 women. This equates to 25.4% of the MOH cases 
in 2012/2013 delivered by emergency caesarean 
section in labour. For 14 of these cases (87.5%), a 
consultant obstetrician was present and in seven 
cases performed the delivery; this reflects a high 
level of compliance for senior staff involvement 
as advised in such cases. The indication for 
half of these operative deliveries in 2012/2013 
was failed instrumental delivery. The indication 
in the other cases related to the presentation, 
failure to progress or fetal bradycardia. There 
were 10 emergency caesarean deliveries at full 
cervical dilatation reported for 2011 accounting 
for 6.7% of the MOH cases for that year and for 
seven of the 10 cases, a consultant obstetrician 
was present.
 2012 2013 2012/13
 (N=164) (N=177) (N=341)
Vaginal 55(33.5) 64(36.2) 119(34.9)
 Spontaneous 37(22.6) 43(24.3) 80(23.5)
 Assisted breech 2(1.2) 1(0.6) 3(0.9)
 Ventouse 5(3.0) 12(6.8) 17(5.0)
 Non-rotational forceps 11(6.7) 8(4.5) 19(5.6)
Caesarean section 101(61.6) 108(61.0) 209(61.3)
 Elective LSCS (no labour) 33(20.1) 37(20.9) 70(20.5)
 Elective LSCS (labour) 2(1.2) 2(1.1) 4(1.2)
 Emergency LSCS (no labour) 27(16.5) 32(18.1) 59(17.3)
 Emergency LSCS (labour) 39(23.8) 35(19.8) 74(21.7)
 Classical 0(0.0) 2(1.1) 2(0.6)
Other 8(4.9) 5(2.8) 13(3.8)
Note: Values are shown as n(%) unless otherwise stated; For two of the 31 cases of multiple birth the mode of delivery differed 
for the babies and the more complex mode of delivery was taken as the primary mode. LSCS=Lower segment caesarean 
section; Other included instances of miscarriage and laparotomy related to cases where the gestational age was less than 
22 weeks.
Table 20: Primary mode of delivery for women who experienced major obstetric haemorrhage 
in 2012 and 2013
Emergency caesarean section delivery at full cervical dilatation
8 Allen VM, O’Connell CM, Baskett TF. Maternal and Perinatal morbidity of caesarean delivery at full cervical dilatation compared 
with caesarean delivery in the first stage of labour. BJOG. 2005; 112:986-90
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9 Clinical Practice Guideline No 17 (2012). Guideline for the Prevention and Management of Primary Postpartum Haemorrhage: 
Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical 
Programmes, Health Service Executive.
It is widely acknowledged that the management 
of MOH requires a multidisciplinary care 
approach with early direct consultant and 
senior staff involvement. Figure 3 illustrates 
the reported presence of health professionals 
during management and care of MOH in each 
of the three years of this audit. An obstetric 
registrar and an anaesthetic registrar were 
present for in excess of 90% of MOH cases and 
theatre staff were present for approximately 
90% of cases each year. There was an increase 
in the documented presence of obstetric 
consultants, senior midwives and anaesthetic 
consultants in cases of MOH over the three 
years.
Management of major obstetric haemorrhage
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Note: Percentages illustrated above were calculated after excluding cases where the presence of the healthcare professional 
was not known.
Placenta praevia and accreta
It has been identified that women with 
placenta praevia/accreta are at very high risk 
of major post-partum haemorrhage.9 There 
were 46 cases of MOH (13.5%) in 2012 and 
2013 which were known cases of placenta 
praevia. There were 16 cases (4.7%) for which 
morbidly adherent placenta was suspected. 
In total, one or both of these risk factors were 
known or suspected for 49 cases of MOH 
(14.4%) in 2012 and 2013. The management 
of these cases is detailed in Table 21 in 
comparison to 23 similar cases reported to 
this audit for 2011. Elective caesarean section 
was planned for three quarters of the 2012/13 
cases compared to approximately 90% of 
the cases in 2011. An obstetric consultant 
was present at the delivery in 86% of cases 
in 2012/2013 compared to 96% of cases in 
2011 and interventional radiology was used 
in just 4% of cases in 2012/2013 compared 
to one in three cases in 2011. Blood salvage 
was planned and occurred in 8% and 6% of the 
cases in 2012/2013, respectively, whereas 
these actions were not reported for known or 
suspected cases of placenta praevia/accreta 
in 2011.
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 Action undertaken 2011 2012/2013
  (N=23) (N=49) 
Elective caesarean section planned 21 (91.3) 38(77.6)
Obstetric consultant present at delivery  22 (95.7) 42(85.7)
Interventional radiology undertaken 8 (35%) 2(4.1)
Blood cell salvage was planned -- 4(8.2)
Blood cell salvage occurred -- 3(6.1)
Table 21: Management of major obstetric haemorrhage cases with known placenta praevia and/or 
suspected placenta accreta
Note: Values are shown as n(%) unless otherwise stated.
Use of uterotonic agents
Current guidelines recommend the routine use 
of prophylactic oxytocin in the management 
of the third stage of labour.10 A prophylactic 
uterotonic agent was administered to at 
least 90% of the women who gave birth and 
experienced MOH. This was the case in each of 
this audit’s three years and despite the high 
prevalence, an increase in the use of these 
agents has been reported, ranging from 91.5% 
in 2011 (n=139 of 152), to 93.5% in 2012 
(n=145 of 156) to 95.3% in 2013 (n=164 of 
172).
For the women who gave birth and experienced 
MOH in 2012 and 2013, there was a difference 
in the specific prophylactic uterotonic agents 
administered (Table 22). Three quarters of 
the women who gave birth by vaginal delivery 
received syntocinon compared to 92% of 
the women delivered by caesarean section. 
Syntometrine was administered twice as often 
to women delivering vaginally compared to 
women who delivered by caesarean section 
(29% vs. 13%). One in eight women received 
both syntocinon and syntometrine (n=39 of 
328, 11.9%) irrespective of mode of delivery 
(vaginal delivery: n=15 of 119, 12.6%; caesarean 
section delivery: n=24 of 209, 11.5%).
The use of uterotonic agents for women 
experiencing MOH associated with uterine 
atony is detailed in Table 23 for the three years 
of this audit in Ireland, 2011-2013. Data from 
the most recent Scottish Confidential Audit 
of Severe Maternal Morbidity, for the year 
2012, have been included for comparative 
purposes. 11
  Vaginal delivery Caesarean section Total
  (N=119) (N=209) (N=328)
Any uterotonic agent 113(95.0) 196(93.8) 309(94.2)
 Syntocinon 90(75.6) 192(91.9) 282(86.0)
 Syntometrine 35(29.4) 27(12.9) 62(18.9)
 Other 8(6.7) 10(4.8) 18(5.5)
Note: Values are shown as n(%) unless otherwise stated. The category ‘Other’ mostly involved the use of ergometrine. More 
than one agent was administered in some cases and therefore the percentages may sum to more than 100%.
Table 22: Use of prophylactic uterotonic agents by mode of delivery for women who gave birth 
and experienced major obstetric haemorrhage in 2012 and 2013
10 Clinical Practice Guideline No 17 (2012). Guideline for the Prevention and Management of Primary Postpartum Haemorrhage: 
Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical 
Programmes, Health Service Executive.
11 Scottish Confidential Audit of Severe Maternal Morbidity: 9th Annual Report (2013). Available from:http://www.
healthcareimprovementscotland.org/our_work/reproductive,_maternal__child/programme_resources/scasmm.aspx
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Uterotonic agent Ireland Ireland Ireland Scotland
 2011 2012 2013 2012
 (N=68) (N=63) (N=67) 
Syntocinon infusion (40 units) 63(92.6) 60(95.2) 65(97.0) 93%
Syntocinon 5-10 units (IM/IV) 50(73.5) 28(44.4) 39(58.2) 61%
Syntometrine 5mg (IM) 22(32.4) 19(30.2) 18(26.9) NR
Ergometrine 0.5mg (IM/IV) 22(32.4) 23(36.5) 28(41.8) 67%
Carboprost 0.25mg (IM) 46(67.6) 44(69.8) 45(67.2) 66%
Misoprostol 200 µg/mcg(PO/PV) 57(83.8) 44(69.8) 48(71.6) 34%
Tranexamic acid 1g 6(8.8) 11(17.5) 7(10.4) NR
Table 23: Uterotonic agent used among women experiencing MOH associated with uterine atony 
in Ireland 2011-2013 and in Scotland 2012
Note: Values are shown as n(%) unless otherwise stated. More than one agent was administered in some cases and therefore 
the percentages may sum to more than 100%. IM=Intramuscular or intra-myometrial; IV=Intravenous; PO=orally; PV=vaginally; 
NR=not reported
Syntocinon infusion was received by over 90% 
of the women in each year in Ireland and there 
was a suggestion of an increase as its use 
ranged from 93% in 2011 to 95% in 2012 and 
97% in 2013. The use of syntocinon infusion 
was similar in Scotland.
Fewer than one in three of the women received 
syntometrine in Ireland and there was a 
suggestion that its use may be diminishing 
in this subgroup of MOH cases. Conversely, 
ergometrine was administered more often 
over the three-year period. However, most 
of the women did not receive ergometrine 
in Ireland whereas two thirds of the women 
experiencing MOH due to uterine atony 
received the drug in Scotland. Carboprost was 
administered in two thirds of cases, in each 
year and in both countries.
There was a far higher reported use of misoprostol 
in Ireland compared with Scotland. This finding is 
surprising given that the current national clinical 
practice guideline on postpartum haemorrhage 
highlights the lack of data supporting the 
efficacy of misoprostal.12,13
12 Clinical Practice Guideline No 17 (2012). Guideline for the Prevention and Management of Primary Postpartum Haemorrhage: 
Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical 
Programmes, Health Service Executive.
13 Mousa HA. & Alfirevic Z. (2007) Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev2007 Jan 
24;(1):CD003249.
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Haemostatic surgical procedures
The incidence of haemostatic surgical 
procedures undertaken for women 
experiencing MOH is detailed in Table 24 for 
the three years of this audit in Ireland, 2011-
2013, and for Scotland for the year 2012, the 
most recent year with available data.14
None of the listed procedures were undertaken 
for 17-25% of the women who experienced 
MOH in Ireland in 2011-2013 (2011: n=29 of 
159, 18.2%; 2012: n=27 of 164, 16.5%; 2013: 
45 of 177, 25.4%).
Intra-uterine balloon tamponade was the most 
common haemostatic surgical procedure 
being undertaken for approximately one in 
four women experiencing MOH each year 
in Ireland and in Scotland. The next most 
common procedure, manual removal of 
placenta/retained tissue was required for 20-
25% of MOH cases in Ireland.
Repair of vaginal/cervical lacerations was 
required less often over the three years in 
Ireland, being undertaken for one in five Irish 
MOH cases in 2011 compared to one in nine 
cases in 2013. There was a halving of the 
incidence of intra-myometrial carboprost 
from 16% in 2011 to 7% in 2013. 
 
Across the three years, a smaller proportion 
of women experiencing MOH required a 
hysterectomy, ranging from 14% in 2011 to 
9% in 2013. Hysterectomy was required for a 
smaller proportion of MOH cases in Scotland.
Re-suturing of caesarean section uterine 
incisions and/or suturing of lateral extensions 
was undertaken for one in nine Irish cases of 
MOH. The remaining procedures (haemostatic 
brace uterine suturing, bilateral ligation of 
uterine arteries, uterine artery embolization 
and bilateral ligation of iliac arteries) were 
relatively rare as they were in Scotland. The 
only possible exception was bilateral ligation 
of uterine arteries which was undertaken for 
3-7% of Irish MOH cases compared to 1% of 
Scottish cases.
Table 24: Haemostatic surgical procedures undertaken for women experiencing major obstetric haemorrhage in 
Ireland 2011-2013 and in Scotland 2012
 Procedure Ireland Ireland Ireland Scotland
  2011 2012 2013 2012
  (N=159) (N=164) (N=177) 
Manual removal of placenta/retained tissue 36(22.6) 41(25.0) 35(19.8) NR
Repair of vaginal/cervical lacerations 33(20.8) 29(17.7) 19(10.7) NR
Re-suturing CS uterine incision 
/ suturing of lateral extension 15(9.4) 18(11.0) 20(11.3) NR
Intra-uterine balloon tamponade 47(29.6) 48(29.3) 44(24.9) 24%
Intra-myometrial carboprost 25(15.7) 21(12.8) 13(7.3) NR
Haemostatic brace uterine suturing 12(7.5) 19(11.6) 12(6.8) 6%
Bilateral ligation of uterine arteries 4(2.5) 11(6.7) 5(2.8) 1%
Uterine artery embolization (interventional radiology) 8(5.0) 2(1.2) 3(1.7) 3%
Bilateral ligation of iliac arteries 1(0.6) 1(0.6) 2(1.1) 1%
Hysterectomy 22(13.8) 18(11.0) 16(9.0) 6%
Note: Values are shown as n(%) unless otherwise stated. More than one agent was administered in some cases and therefore the percentages may sum to 
more than 100%. CS=caesarean section; NR=not reported
14 Scottish Confidential Audit of Severe Maternal Morbidity: 9th Annual Report (2013). Available from:http://www.
healthcareimprovementscotland.org/our_work/reproductive,_maternal__child/programme_resources/scasmm.aspx
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15 Clinical Practice Guideline No 17 (2012). Guideline for the Prevention and Management of Primary Postpartum Haemorrhage: 
Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical 
Programmes, Health Service Executive.
Blood transfusion, resuscitation and monitoring
Actions undertaken related to the resuscitation 
of the MOH patients in 2012/2013 are detailed in 
Table 25. For the vast majority, venous access was 
obtained, two large venous cannulae were sited 
and oxygen given. This is in keeping with national 
guidelines on postpartum haemorrhage.15
With respect to intravenous fluid replacement while 
awaiting compatible blood, national guidelines 
recommend a maximum total volume of 3.5 litres 
of clear fluids (up to 2 litres of crystalloid followed 
by up to 1.5 litres of colloid).15 The recommended 
3.5 litre maximum was exceeded in 15% of MOH 
cases with available data (n=43 of 289, 14.9%). One 
in four cases received over 2 litres of crystalloid 
(n=74 of 290, 25.5%). Fifty-five women (16.1%) did 
not receive a colloid solution. Of those that did, one 
in ten were reported to have received more than 1.5 
litres (n=23 of 240, 9.6%).
Of the 341 cases of MOH in 2012 and 2013, 93% 
(n=318, 93.3%) were reported as having received 
a blood transfusion, as was reported for cases of 
MOH in 2011. Of the 23 cases of MOH who were 
not reported to have received a blood transfusion 
in 2012/2013 (including three cases with missing 
data), three women were reported as having 
refused the transfusion.
Of the 318 MOH cases reported to have 
received a blood transfusion, the total number 
of units transfused was specified for 298 
(93.8%) and ranged from one to 24 units. The 
vast majority of these women received 2-6 
units (n=236, 79.2%). Types of transfusions 
and the range of units transfused are detailed 
in Table 26.
Table 25: Actions undertaken related to the resuscitation of women who experienced major 
obstetric haemorrhage in 2012 and 2013
 n(%)
Venous access achieved prior to the event 314(92.1)
Venous access achieved during the event 274(80.4)
Two large venous cannulae sited 304(89.1)
Oxygen given 287(84.2)
Blood transfusion performed 318(93.3)
Specialist equipment used to provide warm, rapid transfusion 198(58.1)
Categories are not mutually exclusive and may add up to over 100%.
Type Number of women Range of units
  transfused transfused
  (N=318) 
Red blood cells  
    “Emergency” O negative blood 82(25.8) 1-18
    Group specific uncross-matched blood 14(4.4) 1-5
    Cross-match blood 274(86.2) 1-24
Blood products  
    Fresh frozen plasma 81(25.5) 1-20
    Fibrinogen concentrate 134(42.1) 1-12
    Platelets 73(23.0) 1-8
    Octoplas 125(39.3) 1-23
    Activated factor VII 3(0.9) 5-16
Table 26: Type of transfusion and units transfused in cases of major obstetric haemorrhage in 
2012 and 2013
Note: Values are shown as n(%) unless otherwise stated. Categories are not mutually exclusive and may add up to over 100%.
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For almost all MOH patients in 2012/2013 
there was regular monitoring of blood 
pressure, pulse and urine output and use of 
a pulse oximeter and Foley catheter (Table 
27). This was also reported for cases in 2011. 
There was a marked increase in the use of 
the obstetric early warning chart. It was used 
for less than half of the MOH patients in 2011 
(n=67, 45%) compared to three quarters of 
MOH patients in 2012/2013.
For 80 MOH cases in 2012/2013, it was 
reported that an obstetric early warning chart 
was not used (data were not recorded for 
seven cases). Just over half of the women in 
these cases were admitted to an ICU (n=42, 
52.5%), a further 28% (n=22, 27.5%) were 
managed in a high dependency room on the 
labour ward and 4% were admitted to a general 
high dependency unit (n=3, 3.8%).
 
 
National guidelines recommend continuous 
close monitoring of women in appropriate 
settings following major postpartum 
haemorrhage and the audit identifies good 
adherence to this advice. Considering all 341 
women who experienced MOH in 2012/2013, 
one in three were admitted to an ICU (n=111 
of 338, 32.8%; data missing for three cases), 
a further 43% (n=146 of 338, 43.2%) were 
managed in a high dependency room on the 
labour ward and 9% were admitted to a general 
high dependency unit (n=29 of 338, 8.6%).
Table 27: Actions undertaken in the monitoring of women who experienced major obstetric 
haemorrhage in 2012 and 2013
 n(%)
Obstetric early warning chart 254(74.5)
Blood pressure monitored (at least every 15 minutes) 334(97.9)
Pulse monitored (at least every 15 minutes) 334(97.9)
Pulse oximeter used 328(96.2)
Foley catheter in-situ 336(98.5)
Urine output measured regularly 332(97.4)
Central venous pressure line 79(23.2)
Arterial line 184(54.0)
Categories are not mutually exclusive and add up to over 100%.
Quality of care in major obstetric haemorrhage
The detailed MOH questionnaire requests 
each unit to self-assess lessons to be learnt 
from care given. Data on the classification of 
management was not provided for 63 cases 
(18.5%). For the other 278 cases of MOH, 
appropriate care was reported for 85.6% 
(n=238), management of 11.5% (n=32) of 
cases was described as incidental suboptimal 
care which did not affect the outcome but 
where lessons could be learned. There were 
eight cases (2.9%) where the management 
of the case was described as suboptimal care 
impacting on the outcome. These viewpoints 
were either based on consensus at a risk 
management meeting (51.7%), clinical case 
presentation (14.8%), informal clinical 
discussion (20.9%) or personal opinion 
(20.2%).
A time delay in access to theatre was reported 
for five cases (1.5%) of major obstetric 
haemorrhage; the approximate wait time 
ranged from 10 to 100 minutes.
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International guidelines on obstetric 
haemorrhage were available for the reporting 
years of this audit and an Irish guideline 
on Prevention and Management of Primary 
Postpartum Haemorrhage has been available 
since 2012.16 For almost all cases (n=337, 
98.8%) it was stated that the unit had a 
protocol for the management of MOH, and in 
the vast majority of cases (n=295, 87.5%) the 
management of the MOH case adhered to the 
protocol. Adherence was not specified in 22 
cases (6.5%) and there were 20 cases (5.9%) 
where the management of the case did not 
adhere to the unit’s protocol.
Frequent monitoring of parameters was 
reported for almost all MOH patients as 
detailed in Table 27 above. The use of obstetric 
early warning charts in the monitoring of 
patients was reported in 75% of cases in 
2012/2013, a marked increase of the 45% 
reported rate of their use for MOH cases in 
2011. This may be related to the lead up to the 
implementation of a national Irish Maternity 
Early Warning System (IMEWS) in 2014.17 
Parameters may also have been recorded on 
flow charts such as high dependency charts.
Summary of learning points described by units
Eight of the reporting units described 
examples of both good practice and learning 
points gleaned in assessment of individual 
MOH cases. The small proportion of units 
describing learning points in detail is perhaps 
disappointing but nevertheless lessons 
identified may be used on a national level 
to improve clinical care. Recurrent reported 
themes are summarised below:
Identified positive practices
•	 Early	 consultant	 and	 senior	 staff	
involvement. 
•	 Multidisciplinary	 approach	 with	 good	
interdisciplinary communication.
•	 On-going	 multidisciplinary	 skills	 and	 drills	
educational programmes.
•	 Pre-delivery	 counselling	 of	 women	 at	
high risk for MOH of the potential need 




in the antenatal period in some high risk 
cases.
•	 Suboptimal	 estimation	 and	 recording	 of	
blood loss.
•	 Requirement	 for	 a	 specific	 proforma	 to	
document management and fluid balance 




impacting on patient care
•	 Challenges	faced	by	a	stand-alone	maternity	
unit when transfer of a woman for critical 
care to another site is required.
16 Clinical Practice Guideline No 17 (2012). Guideline for the Prevention and Management of Primary Postpartum Haemorrhage: 
Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical 
Programmes, Health Service Executive. 
17 Clinical Practice Guideline No 25 (2014). The Irish Maternity Early Warning System (IMEWS)
Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical 
Programmes, Health Service Executive
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18 Murphy, CM, Murad, K, Deane, R, Byrne, B, Geary, MP, Mc Auliffe, FM. Severe maternal morbidity for 2004-2005 in the three 
Dublin maternity hospitals. Eur J Obstet Gynecol 2009: 143:34-37
19  Knight M, Kurinczuk JJ, Spark P and Brocklehurst P. United Kingdom Obstetric Surveillance System
(UKOSS) Annual Report 2007. National Perinatal Epidemiology Unit, Oxford.
20 Kwee A, Bots ML, Visser GH, Bruinse HW. Emergency peripartum hysterectomy:a prospective study in The Netherlands. Eur J 
Obstet Gynecol Reprod Biol 2006;124(2):187–92
For the combined years 2012 and 2013, 42 
cases of peripartum hysterectomy (PH) 
were reported by contributing units giving a 
national rate of 0.31 per 1,000 maternities or 
approximately one in every 3,200 maternities. 
There was no clustering of PH cases identified 
in any one maternity unit. As mentioned 
earlier, the PH rate found in this audit is 
similar to that of a previous Irish study18, and 
to national rates reported in the UK and the 
Netherlands of 0.41 and 0.33 per 1,000 births 
respectively.19,20
Eight of the reported cases of PH were not 
associated with major obstetric haemorrhage 
(MOH) as defined in this audit. All eight were 
delivered by caesarean section prior to labour 
with three hysterectomies being reported as a 
planned procedure. The indication for delivery 
in this cohort was morbidly adherent placenta 
in the majority of these cases (n=5) with a 
further three cases reporting cervical cancer, 
uterine anomaly and uterine rupture (in a 
case of chorioangioma in a molar pregnancy).
Of the 34 cases of PH associated with MOH, 
the reported cause of haemorrhage was not 
always attributed exclusively to one clinical 
risk factor (Table 28). For almost half of 
the cases (47.1%) there was more than one 
reported cause of MOH. The most commonly 
reported causes were placenta praevia (n=18, 
52.9%), morbidly adherent placenta (n=14, 
41.2%), uterine atony (n=11, 32.4%) and 
bleeding from uterine incision (n=7, 20.6%). A 
planned interventional radiology was carried 
out in two cases. Uterine rupture was not an 
identified cause of haemorrhage in any case 
of PH associated with MOH in this cohort.
Peripartum hysterectomy
 Associated cause Only cause
 n % n %
Morbidly adherent placenta 14 41.2 1 2.9
Placenta praevia 18 52.9 5 14.7
Uterine atony 11 32.4 5 14.7
Cervical laceration 1 2.9 1 2.9
Bleeding from uterine incision 7 20.6 4 11.8
Other cause* 4 11.8 2 5.9
Table 28: Cause of major obstetric haemorrhage in women experiencing peripartum 
hysterectomy in 2012 and 2013
*Other cause includes infection and other specific causes
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Haemostatic surgical procedures
The reported incidence of haemostatic surgical 
procedures undertaken for the 34 women who 
experienced MOH and required a hysterectomy 
in Ireland in 2012 and 2013 is detailed in Table 
29. Early recourse to PH is recommended when 
conservative measures fail to arrest obstetric 
bleeding, especially where bleeding is associated 
with placenta accrete or uterine rupture, and should 
not be delayed until the woman is in extremis.21
Mode of delivery
Caesarean section was the mode of delivery 
for all but one of the 42 women requiring 
PH with the majority (n= 32, 78%) carried 
out prior to the onset of labour (Table 30). 
The NPEC detailed audit form on MOH seeks to 
record the grade of the obstetrician performing 
the caesarean section. This was recorded for 30 
of the 34 women who had a PH associated with 
MOH. For three quarters of these cases (n=23, 
76.7%) the caesarean section was carried by a 
consultant obstetrician. A registrar or specialist 
registrar carried out the procedure in five 
(16.7%) and two (6.7%) cases, respectively. For 
these seven cases, a consultant obstetrician 
was present for four deliveries and was informed 
of the other three cases.
21 Clinical Practice Guideline No 17 (2012). Guideline for the Prevention and Management of Primary Postpartum Haemorrhage: 
Institute of Obstetricians and Gynaecologists, Royal College of Physicians of Ireland and Directorate of Strategy and Clinical 
Programmes, Health Service Executive.
Table 29: Haemostatic surgical procedures undertaken for women who experienced major 
obstetric haemorrhage and required a hysterectomy in Ireland in 2012 and 2013
Table 30: Mode of delivery in women experiencing peripartum hysterectomy in 2012 and 2013
Procedure (N=34)
Intra-uterine balloon tamponade 10(29.4)
Manual removal of placenta/retained tissue 5(14.7)
Repair of vaginal/cervical lacerations 1(2.9)
Intra-myometrial carboprost 2(5.9)
Re-suturing CS uterine incision/ suturing of lateral extension 3(8.8)
Haemostatic brace uterine suturing 4(11.8)
Bilateral ligation of uterine arteries 5(14.7)
Uterine artery embolization (interventional radiology) 2(5.9)
Bilateral ligation of iliac arteries 1(2.9)
Mode of delivery (N=41)*
Non-rotational forceps vaginal delivery 1(2.4)
Elective LSCS not in labour 20(48.8)
Elective LSCS in labour 1(2.4)
Emergency LSCS not in labour 12(29.3)
Emergency LSCS in labour  5(12.2)
Classical caesarean section 2(4.9)
Categories are not mutually exclusive and add up to over 100%.
Note: Values are shown as n(%) unless otherwise stated. * Mode of delivery was not known for one case. 
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Co-morbidities
A number of severe maternal co-morbidities, 
as defined in this audit, were associated with 
women who had a PH (Table 31). As mentioned 
above, the vast majority experienced MOH. 
Over half (n=23, 54.8%) of the women were 
admitted to ICU and four (9.5%) of the cases 
were complicated by a pulmonary embolism. 
Notwithstanding the small numbers involved, 
this suggests that the risk of pulmonary 
embolism in cases of PH (4 of 42, i.e. 95 per 
1,000 maternities) is several hundred times 
greater than the risk in all maternities (0.27 per 
1,000; rate ratio = 352, 95% confidence interval 
= 125-989, p-value < 0.001).
Causal factors
A number of studies over the last decade have 
identified an association between PH, previous 
caesarean section and placenta accreta.22,23,24 
In this audit, data on previous caesarean section 
in cases of PH was available for 35 women. The 
majority of these (n=28, 80.0%) had a previous 
caesarean section with over half (n=19, 54.3%) 
having two or more previous caesarean sections 
(Table 32).
Morbidly adherent placenta was a causal factor 
for PH in half of the 35 cases with data on history 
of previous caesarean section (n=17, 48.6%). All 
but one of the women in these 17 cases (n=16, 
94.1%) had a previous caesarean section with 
most (11, 64.7%) having two or more previous 
caesarean sections (Table 31).
Table 31: Severe maternal morbidity associated with women experiencing peripartum 
hysterectomy in 2012 and 2013
 (N=42)




Acute respiratory dysfunction 1(2.4)
 Number of  Placenta Morbidly Praevia and  Other Total 
 previous  praevia adherent  morbidly  causes 
 caesarean sections  placenta adherent placenta
 0 1 0 1 5 7(20.0)
 1 0 1 4 4 9(25.7)
 ≥2 5 2 9 3 19(54.3)
 Total 6(17.1) 3(8.6) 14(40.0) 12(34.3) 35(100)
Table 32: Causal factors in 2012 and 2013 cases of peripartum hysterectomy by number of previous 
caesarean sections
Note: Excludes missing data for seven of 42 cases of peripartum hysterectomy; Values are shown as n(%) unless otherwise stated. Other 
causes were uterine atony (n=6), bleeding from uterine incision (n=4); infection (n=1) and cervical laceration (n=1).
22 Knight M, Kurinczuk J, Spark P,and  Brocklehurst P, for the UKOSS. Cesarean Delivery and Peripartum Hysterectomy. American 
college of Obstetricians and Gynaecologists 2008 Vol111, No.1 97-105
23 Flood K, Said S, Geary M, Robson M, Fitzpatrick C and Malone F. Changing trends in peripartum hysterectomy over the last 4 
decades. Am J Obstet Gynecol 2009;200:632.e1-632.e6.
24 Kwee A, Bots ML, Visser GH, Bruinse HW. Emergency peripartum hysterectomy: a prospective study in The Netherlands. Eur J 
Obstet Gynecol Reprod Biol 2006;124:187–92.
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Appendix A: National Office of Clinical Audit Governance 
Board endorsement of Severe Maternal Morbidity in 
Ireland Annual Report 2012 and 2013
 
 
Professor Richard A. Greene 
Director 
National Perinatal Epidemiology Centre 









Dear Professor Greene, 
 
I write to thank you and your colleagues Dr Paul Corcoran and Edel Manning, for your detailed 
presentation to the NOCA Governance Board, 15th April 2015 of NPEC’s Severe Maternal Morbidity in 
Ireland - Annual Report 2012 & 2013. 
  
You and the extended NPEC Team, Advisory Groups and hospital data collectors are to be 
commended for this work.  This report serves to highlight the value of sustainable audit to inform 
quality improvement of obstetric care in Ireland.    
 
As discussed with the NOCA Board, variances noted between ICU admissions nationally and the need 
to carry out a full review would be extremely beneficial and help inform service delivery of critical 
care for obstetrics.  We look forward to the output of such a review. 
 
The NOCA Board and Executive Team will continue to support NPEC governance efforts and in 
particular highlight the national requirement for resource commitment to ensure sustainable clinical 
audit of perinatal and maternal outcomes. 
 
Please accept this as formal endorsement from the NOCA Board of the Severe Maternal Morbidity in 








Professor Sean Tierney  
Chairman 
National Office of Clinical Audit 
National Office of Clinical Audit, 4th Floor, 121 St. Stephen’s Green, Dublin 2   Tel: 4028577                          
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Hospital Co-ordinators Additional contributors
Cavan General Hospital Dr Rukhsana Majeed Dr Salah Aziz, 
 Ms Karen Malocca  Ms Margaret Mulvany
Coombe Women and Infants Dr Bridgette Byrne
University Hospital 
Cork University Ms Katie Burke Dr Miriam Harnett
Maternity Hospital  Ms Geraldine Hayes 
Kerry General Hospital, Tralee Ms Claire Fleming Kelliher
 Ms Mary Stack Courtney 
Letterkenny General Hospital Ms Raphael Dalton, Ms Mary Doherty,  Ms Evelyn Smith
 Ms Geraldine Hanley, Ms Mary Lynch 
Mayo General Hospital,  Ms Pauline Corcoran Dr Hilary Ikele
Castlebar Ms Diane Brady Dr Meabh Ní Bhuinneain
Midland Regional Hospital,  Ms Marie Corbett
Mullingar 
Midland Regional Hospital, Ms Ita Kinsella Dr Miriam Doyle
Portlaoise Ms Emma Mullins 
Mid-Western Regional  Ms Therese O Donoghue
Maternity Hospital, Limerick  
Mount Carmel Hospital, Dublin Ms Catherine Halloran Dr Valerie Donnelly
 Ms Felicity Doddy  
National Maternity Hospital,  Dr  Jennifer Hogan
Dublin  Dr Vicky O Dwyer  
Our Lady of Lourdes Hospital,  Ms Anne Keating Dr Seosamh Ó Cóigligh
Drogheda
Portiuncula Hospital, Ballinasloe Ms Mary Burke 
Rotunda Hospital, Dublin Dr Sharon Cooley 
Sligo General Hospital Ms Juliana Henry Dr Heather Langan
South Tipperary General Hospital,  Ms Siobhan Kavanagh
Clonmel  
St Luke’s Hospital, Kilkenny Ms Connie McDonagh 
University Hospital Galway Ms Siobhan Canny Dr Geraldine Gaffney
Waterford Regional Hospital Ms Janet Murphy 
Wexford General Hospital Ms Helen McLoughlin 
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Edel Manning, Research Midwife
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Obstetric Haemorrhage Documentation 
Date … /… /…. Time ……………………….... 
Clinical Area…………………….. 
Person completing form …………………..Staff Grade………………… 
Signature …………………..…………… 
Primary Cause of Obstetric Haemorrhage…………………………………………………………… 
Total Estimated Blood Loss …………………….   




 Name Time informed Time arrived 
Clinical Midwife Manager    
Porter    
Consultant Obstetrician    
Consultant Anaesthetist    
Haematologist (or when 
contacted blood bank) 
  N/A 
Other Staff present Status Other Staff present  Status 
    
    
    
    
    
Management Time Treatment  Dose Time Order 
 Assess CAB, position & 
observations (MEWS) 
 




Oxygen  IM Syntometrine    
Cannula 1: Colour…………………  Syntocinon infusion    




1    
Clotting screen &  Cross match  2    
Crystalloids  3    
Assess urgency for transfusion  4    
Catheter   Further 
doses 
   
Bimanual compression      
Repair perineal trauma       
Blood products Amount Time Further management Details 
RBC   
Theatre 
EUA  
FFP   B-Lynch  
Platelets   Balloon  
Cell salvage   Hysterectomy   
Other 
information 
Blood warmer used           Yes⁬ No⁬  I Radiology  
Body warmer used            Yes⁬ No⁬ Arterial line Yes⁬ No⁬ 
Debrief  Staff   Yes⁬ No⁬      Woman/partner Yes⁬ No⁬ HDU care/ ICU transfer Yes⁬ No⁬ 
Mother’s Name ____________________ 
Date of birth ______________________ 
Hospital Number __________________ 
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CONFIDENTIAL AUDIT  
OF 
SEVERE MATERNAL MORBIDITY IN IRELAND   
 
Notification Form:  2013  
 
 
Hospital Name _____________________________________________________ 
 
Completed by _____________________________________________________ 
(Please print name and staff grade)                            
  
Date of event:       
 






Height at booking   ____________cm 
 
Weight at booking ____________kg 
* NPEC case number   
 
 
BMI    Parity:   + 
                                                                         
(Status prior to delivery) 
Date of delivery:   //Gestation at delivery/pregnancy end     
(or pregnancy end)                                                                                                   (Completed weeks)                                                                                                                                                                                                                                                                                                     
                                            
1. Ethnic group: 
White Irish              Irish Traveller     
 Any other White background      Please specify country of origin   _____________________ 
 Asian or Asian Irish                                                         Black or Black Irish     
 Other, including mixed ethnic backgrounds:                           Not recorded        
Number*:   Age  
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2 
 
2.a. Did the woman smoke at booking?         Yes    please specify quantity _____________ 
                                     No         Not recorded   
2b. Did she give up smoking during pregnancy?  Yes     No       Not recorded   N/A   
3. Did the woman drink alcohol at booking?          Yes     No    Not recorded   
4.  Is there documented history of drug abuse or attendance at a drug rehabilitation unit? 
              None recorded                 Prior to this pregnancy               During this pregnancy   
 
 
5. Mode of delivery: 
      
 
 Baby 1 Baby 2*  Baby 1 Baby 2* 
              
i) Spontaneous vaginal  
delivery       
vi) Elective LSCS not 
in labour      
 
              
ii) Assisted vaginal   
breech delivery       
vii) Elective LSCS in 
labour      
 
              
iii) Ventouse vaginal   
delivery       
viii) Emergency LSCS 
not in labour      
 
 
iv) Non-rotational forceps  
vaginal delivery       
ix) Emergency LSCS 
in labour      
 
 
v) Rotational forceps  
vaginal delivery       
x) Classical 






Please answer yes or no as applicable  
Baby Outcomes Baby 1 Baby 2 Baby 3 
Birth weight in grams    
Intubation following delivery     
Transferred to SBCU/NICU    
*Early Neonatal Death     
*Late Neonatal Death      
Intrauterine death ≥ 500g    
*Miscarriage    







Maternal Morbidity Category 
(See page 4 for definitions) 
Please tick all that apply 
1. Major obstetric haemorrhage*  
2. Uterine rupture  
3. Peripartum hysterectomy* 
*please specify indication for peripartum hysterectomy  
4. Eclampsia  
5. Renal or liver dysfunction  
6. Pulmonary oedema  
7. Acute respiratory dysfunction  
8. Pulmonary embolism  
9. Cardiac arrest  
10. Coma  
11. Cerebro-vascular event  
12. Status epilepticus  
13. Septicaemic shock  
14. Anaesthetic problem  
15. ICU/CCU admission* 





16. Other severe morbidity, please specify  
17. Interventional radiology (IR)*                        17a Planned                                                                                                                                               
                                                                                  17b. Unplanned  
 
* For categories 1 (Major Obstetric Haemorrhage) and 17 (Interventional Radiology), please complete 
the NPEC Major Obstetric Haemorrhage Audit Form  
 



















Please notify all categories of Severe Maternal Morbidity, as outlined above,  occurring 
during pregnancy or up to 42 days following delivery, miscarriage, termination of pregnancy 












Maternal Morbidity Definitions 
1 Major obstetric haemorrhage 
Estimated blood loss ≥ 2500ml, or transfused 5 or more units of blood 
or received treatment for coagulopathy (Fresh Frozen Plasma; 
Fibrinogen Concentrate Substitution Therapy; Platelets)   
(Also includes ectopic pregnancy meeting these criteria) 
2 Uterine rupture 
A complete separation of the wall of the pregnant uterus, with or 
without expulsion of the fetus, involving rupture of membranes at the 
site of the uterine rupture or extension into uterine muscle separate 
from any previous scar, and endangering the life of the mother or 
fetus. 
Excluded: any asymptomatic palpable or visualised defect (e.g. 
dehiscence noted incidentally at caesarean delivery) 
3 Peripartum hysterectomy Peripartum hysterectomy 
4 Eclampsia Seizure associated with antepartum, intrapartum or postpartum symptoms and signs of pre-eclampsia 
5 Renal or liver dysfunction 
Acute onset of biochemical disturbance, urea >15mmol/l, 
creatinine>400mmol/l, AST/ALT >200u/l 
6 Pulmonary oedema 
Clinically diagnosed pulmonary oedema associated with acute 
breathlessness and O2 saturation <95%, requiring O2, diuretics or 
ventilation 
7 Acute respiratory dysfunction 
Requiring intubation or ventilation for >60 minutes (not including 
duration of general anaesthetic) 
8 Pulmonary embolism 
Increased respiratory rate (>20/min), tachycardia, hypotension. 
Diagnosed as “high” probability on V/Q scan or positive spiral chest 
CT scan. Treated by heparin, thrombolysis or embolectomy 
9 Cardiac arrest No detectable major pulse 
10 Coma Including diabetic coma. Unconscious for >12 hours 
11 Cerebro-vascular event 
Stroke, cerebral/cerebellar haemorrhage or infarction, subarachnoid 
haemorrhage, dural venous sinus thrombosis 
12 Status epilepticus Constant or near constant state of having seizures that last 30mins or more 
13 Septicaemic shock Shock (systolic blood pressure <80) in association with infection. No other cause for decreased blood pressure. Pulse of 120bpm or more 
14 Anaesthetic problem Aspiration, failed intubation, high spinal or epidural anaesthetic 
15 ICU/CCU admission Unit equipped to ventilate adults. Admission for one of the above problems or for any other reason. Includes CCU admissions 
16 Other severe morbidity Other severe morbidity, e.g. amniotic fluid embolism 
17 Interventional radiology Received planned (a) or unplanned (b)  interventional radiology 

National Perinatal Epidemiology Centre, 
Department of Obstetrics and Gynaecology, UCC, 
5th Floor, Cork University Maternity Hospital, Wilton, Cork, Ireland
T: +353 21 4205017   E: npec@ucc.ie   W: www.ucc.ie/en/npec/
